Form 4 Tracker
Atul Pande

Director · 6 filings · Latest: Aug 28, 2026

Immunovant, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
IMVT
Atul PandeDirectorAug 28, 2026
Sale
$43.271,500$64.9K116,731
IMVT
Atul PandeDirectorAug 28, 2026
Option Exercise
$8.431,500$12.6K118,231
IMVT
Atul PandeDirectorJul 24, 2026
Sale
$39.801,500$59.7K116,731
IMVT
Atul PandeDirectorJul 24, 2026
Option Exercise
$8.431,500$12.6K118,231
IMVT
Atul PandeDirectorJun 26, 2026
Sale
$38.011,500$57.0K116,731
IMVT
Atul PandeDirectorJun 26, 2026
Option Exercise
$8.431,500$12.6K118,231
IMVT
Atul PandeDirectorJun 15, 2026
Sale
$34.021,500$51.0K116,731
IMVT
Atul PandeDirectorJun 15, 2026
Option Exercise
$8.431,500$12.6K118,231
IMVT
Atul Pande—Jun 15, 2026
Proposed Sale
$33.626,000$201.7K—
IMVT
Atul PandeDirectorMay 20, 2026
Sale
$32.006,000$192.0K116,731
IMVT
Atul PandeDirectorMay 20, 2026
Option Exercise
$8.436,000$50.6K122,731
IMVT
Atul Pande—May 20, 2026
Proposed Sale
$26.296,000$157.7K—
IMVT
ATUL CHANDRA PANDE—Dec 2, 2024
Proposed Sale
$28.207,750$218.6K—